Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of corneal vascularization.

Andrew J W Huang1, De-Quan Li, Cheng-Hui Li

  • 1Department of Ophthalmology, University of Minnesota, Minneapolis, Minnesota 55455, USA. huang088@umn.edu

The Ocular Surface
|January 12, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Underwater Self-Healing Polysulfide Elastomer with In-Situ Curing and Adhesion.

Polymer science & technology (Washington, D.C.)·2026
Same author

Conjunctival Biopsy in Ocular Mucous Membrane Pemphigoid.

American journal of ophthalmology·2026
Same author

Retraction: Planar chiral orange-red TADF materials with AIE properties for efficient circularly polarized OLEDs.

Chemical communications (Cambridge, England)·2026
Same author

Strain resilient and self-healing nanocomposite conductors with ultralow sheet resistance.

Nature communications·2026
Same author

Thinner-than-paper and broad-temperature-adaptive zinc-iodine batteries enabled by nanophase separated deep-eutectic hydrogel electrolytes.

Nature communications·2026
Same author

Understanding the Impact of Grafted Chain Length in Polymer Electrolytes with Nonlinear Architectures.

Macromolecules·2026

Corneal avascularity relies on a balance of growth factors. Disrupting this balance causes pathological corneal vascularization, increasing graft rejection risk. Novel therapies targeting these factors show promise.

Area of Science:

  • Ophthalmology
  • Angiogenesis Research
  • Corneal Biology

Background:

  • Normal cornea avascularity is maintained by a balance between anti-angiogenic and pro-angiogenic stimuli.
  • Ocular surface epithelia possess unique characteristics that regulate corneal avascularity.
  • The conjunctiva, unlike the cornea, contains pro-angiogenic factors like basic fibroblast growth factor (bFGF).

Purpose of the Study:

  • To explore the mechanisms regulating corneal avascularity and the consequences of its disruption.
  • To investigate the role of angiogenic and anti-angiogenic factors in pathological corneal vascularization.
  • To assess the therapeutic potential of novel treatments targeting corneal neovascularization.

Main Methods:

  • Analysis of the homeostatic mechanisms governing corneal avascularity.

Related Experiment Videos

  • Investigation of the role of heparan sulfate, angiogenic cytokines (e.g., bFGF), and angiostatic factors (e.g., endostatin) in corneal avascularity.
  • Examination of the function of matrix metalloproteinases (MMPs) and other enzymes in corneal vascularization.
  • Review of novel therapeutic strategies targeting angiogenic pathways and MMPs in preclinical models.

    • Main Results:

    • Disruption of the angiogenic balance during corneal wound healing leads to pathological vascularization.
    • Heparan sulfate in Bowman's layer prevents bFGF release, maintaining avascularity.
    • Degradation of the corneal extracellular matrix can release angiostatic factors.
    • Vascularization allows inflammatory cell infiltration, increasing immune sensitization and graft rejection risk.
    • Therapies targeting angiogenic cytokines or MMPs have effectively suppressed corneal vascularization in animal models.

    Conclusions:

    • Maintaining corneal avascularity is crucial for ocular health and successful corneal transplantation.
    • Understanding the molecular mechanisms of corneal neovascularization is key to developing effective treatments.
    • Targeting angiogenic pathways and MMPs presents a promising therapeutic strategy for managing pathological corneal vascularization.